Trials / Unknown
UnknownNCT01034319
Genetic Counseling and Lifestyle Change for Diabetes Prevention
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the impact diabetes genetic counseling on patient motivation and disease prevention behaviors among subjects with pre-diabetes. Intervention subjects will be provided with their individual diabetes genotype risk score derived from aggregating the combined results of 37 diabetes risk-associated genetic loci. Controls will not be tested. All subjects will be enrolled in a 12-week diabetes prevention program.
Detailed description
This study will examine the impact diabetes genetic counseling on patient motivation and disease prevention behaviors among subjects with pre-diabetes. We will randomize subjects with pre-diabetes to genetic testing vs. no genetic testing in order to obtain an unconfounded test of the hypothesis that genetic testing will change patient behavior. Intervention subjects will be provided with their individual diabetes genotype risk score derived from aggregating the combined results of 37 diabetes risk-associated genetic loci. Because patients can receive either "Higher risk" or "Lower risk" genetic test results, we will separately examine the impact of "Higher risk" and "Lower risk" test results compared to untested controls. All subjects will be enrolled in a 12-week diabetes prevention program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Diabetes Genetic Counseling | Subjects will be genotyped based on a 37-allele aggregate score and counseled regarding the implications of the results prior to enrollment in a 12-week diabetes prevention program |
| BEHAVIORAL | No genetic counseling | These subjects will not be genotyped or counseled prior to enrollment in a 12-week diabetes prevention program |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-08-01
- Completion
- 2012-12-01
- First posted
- 2009-12-17
- Last updated
- 2011-07-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01034319. Inclusion in this directory is not an endorsement.